Thermo Fisher Webinars
-
Maximizing Media Strategies: Expert Insights On Boosting Performance
5/22/2025
Optimize biopharma media strategies for consistent protein quality. Experts discuss formats, variability, and actionable analytics in this on-demand virtual roundtable.
-
Implementing Rapid Microbial Identification In Biotherapy Manufacutring
5/27/2025
Learn about rapid microbial identification strategies that enhance environmental monitoring and compliance with regulatory requirements for your manufacturing processes.
-
Enhancing Protein Quality Through Optimized Galactosylation
7/23/2025
Advance your understanding of critical protein engineering. Explore expert strategies for optimizing complex molecular structures, paving the way for more effective and consistent biological products.
-
Advancing The Purification Of VSV-G Pseudotyped Lentiviral Vector
6/9/2025
Discover new strategies to overcome lentiviral purification challenges with a scalable approach that maintains viral infectivity through gentle processing conditions.
-
Leveraging dPCR r Techniques To Quantitate Lentivirus Particles
5/28/2025
Discover how digital PCR can streamline lentiviral vector characterization to reduce variability and improve analytical sensitivity. Learn how this approach can help you comply with regulatory guidance.
-
Innovative Strategies For Residual DNA And Viral Titre Quantitation
5/22/2025
Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.
-
Key Considerations For Rapid Microbial Methods For Mycoplasma Detection
5/29/2025
Learn the importance of demonstrating product specific suitability, defining representative sample, consistent sampling protocols, accommodating volume and turnaround time constraints, and the need to establish equivalence.
-
Driving Measurable Productivity Gains In CHO Cell Culture
8/25/2026
Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.
-
Efficient Scale-Up Of Monoclonal Antibody Production: From Bench Top To 500L
8/11/2025
Scaling monoclonal antibody production from the lab to a commercial scale can be challenging. Learn about an approach that helps you maintain consistent productivity and product quality across all scales.
-
Scaling Plasmid DNA Production: A Proven Strategy For Higher Yields
8/27/2025
Learn how an agile manufacturing partner scaled their plasmid DNA production and achieved higher yields by optimizing their media selection and fermentation processes.